NCT00363649 2018-11-13
Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Leukemia, Myeloid, Chronic-Phase × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all